CTT Pharmaceutical CEO Ryan Khouri reports purchase of 2,100 shares worth $115.50
CTTH•CEO share purchase reported
CTT Pharmaceutical Holdings reported CEO Ryan Khouri bought 2,100 CTTH shares at $0.06 each.
- Directly held stake rose to 9,360,756 shares following the purchase.
